Cargando…

The Saccadic and Neurological Deficits in Type 3 Gaucher Disease

Our objective was to characterize the saccadic eye movements in patients with type 3 Gaucher disease (chronic neuronopathic) in relationship to neurological and neurophysiological abnormalities. For approximately 4 years, we prospectively followed a cohort of 15 patients with Gaucher type 3, ages 8–...

Descripción completa

Detalles Bibliográficos
Autores principales: Benko, William, Ries, Markus, Wiggs, Edythe A., Brady, Roscoe O., Schiffmann, Raphael, FitzGibbon, Edmond J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140522/
https://www.ncbi.nlm.nih.gov/pubmed/21799847
http://dx.doi.org/10.1371/journal.pone.0022410
_version_ 1782208571393441792
author Benko, William
Ries, Markus
Wiggs, Edythe A.
Brady, Roscoe O.
Schiffmann, Raphael
FitzGibbon, Edmond J.
author_facet Benko, William
Ries, Markus
Wiggs, Edythe A.
Brady, Roscoe O.
Schiffmann, Raphael
FitzGibbon, Edmond J.
author_sort Benko, William
collection PubMed
description Our objective was to characterize the saccadic eye movements in patients with type 3 Gaucher disease (chronic neuronopathic) in relationship to neurological and neurophysiological abnormalities. For approximately 4 years, we prospectively followed a cohort of 15 patients with Gaucher type 3, ages 8–28 years, by measuring saccadic eye movements using the scleral search coil method. We found that patients with type 3 Gaucher disease had a significantly higher regression slope of duration vs amplitude and peak duration vs amplitude compared to healthy controls for both horizontal and vertical saccades. Saccadic latency was significantly increased for horizontal saccades only. Downward saccades were more affected than upward saccades. Saccade abnormalities increased over time in some patients reflecting the slowly progressive nature of the disease. Phase plane plots showed individually characteristic patterns of abnormal saccade trajectories. Oculo-manual dexterity scores on the Purdue Pegboard test were low in virtually all patients, even in those with normal cognitive function. Vertical saccade peak duration vs amplitude slope significantly correlated with IQ and with the performance on the Purdue Pegboard but not with the brainstem and somatosensory evoked potentials. We conclude that, in patients with Gaucher disease type 3, saccadic eye movements and oculo-manual dexterity are representative neurological functions for longitudinal studies and can probably be used as endpoints for therapeutic clinical trials. TRIAL REGISTRATION: ClinicalTrials.gov NCT00001289
format Online
Article
Text
id pubmed-3140522
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-31405222011-07-28 The Saccadic and Neurological Deficits in Type 3 Gaucher Disease Benko, William Ries, Markus Wiggs, Edythe A. Brady, Roscoe O. Schiffmann, Raphael FitzGibbon, Edmond J. PLoS One Research Article Our objective was to characterize the saccadic eye movements in patients with type 3 Gaucher disease (chronic neuronopathic) in relationship to neurological and neurophysiological abnormalities. For approximately 4 years, we prospectively followed a cohort of 15 patients with Gaucher type 3, ages 8–28 years, by measuring saccadic eye movements using the scleral search coil method. We found that patients with type 3 Gaucher disease had a significantly higher regression slope of duration vs amplitude and peak duration vs amplitude compared to healthy controls for both horizontal and vertical saccades. Saccadic latency was significantly increased for horizontal saccades only. Downward saccades were more affected than upward saccades. Saccade abnormalities increased over time in some patients reflecting the slowly progressive nature of the disease. Phase plane plots showed individually characteristic patterns of abnormal saccade trajectories. Oculo-manual dexterity scores on the Purdue Pegboard test were low in virtually all patients, even in those with normal cognitive function. Vertical saccade peak duration vs amplitude slope significantly correlated with IQ and with the performance on the Purdue Pegboard but not with the brainstem and somatosensory evoked potentials. We conclude that, in patients with Gaucher disease type 3, saccadic eye movements and oculo-manual dexterity are representative neurological functions for longitudinal studies and can probably be used as endpoints for therapeutic clinical trials. TRIAL REGISTRATION: ClinicalTrials.gov NCT00001289 Public Library of Science 2011-07-20 /pmc/articles/PMC3140522/ /pubmed/21799847 http://dx.doi.org/10.1371/journal.pone.0022410 Text en This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication. https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
spellingShingle Research Article
Benko, William
Ries, Markus
Wiggs, Edythe A.
Brady, Roscoe O.
Schiffmann, Raphael
FitzGibbon, Edmond J.
The Saccadic and Neurological Deficits in Type 3 Gaucher Disease
title The Saccadic and Neurological Deficits in Type 3 Gaucher Disease
title_full The Saccadic and Neurological Deficits in Type 3 Gaucher Disease
title_fullStr The Saccadic and Neurological Deficits in Type 3 Gaucher Disease
title_full_unstemmed The Saccadic and Neurological Deficits in Type 3 Gaucher Disease
title_short The Saccadic and Neurological Deficits in Type 3 Gaucher Disease
title_sort saccadic and neurological deficits in type 3 gaucher disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140522/
https://www.ncbi.nlm.nih.gov/pubmed/21799847
http://dx.doi.org/10.1371/journal.pone.0022410
work_keys_str_mv AT benkowilliam thesaccadicandneurologicaldeficitsintype3gaucherdisease
AT riesmarkus thesaccadicandneurologicaldeficitsintype3gaucherdisease
AT wiggsedythea thesaccadicandneurologicaldeficitsintype3gaucherdisease
AT bradyroscoeo thesaccadicandneurologicaldeficitsintype3gaucherdisease
AT schiffmannraphael thesaccadicandneurologicaldeficitsintype3gaucherdisease
AT fitzgibbonedmondj thesaccadicandneurologicaldeficitsintype3gaucherdisease
AT benkowilliam saccadicandneurologicaldeficitsintype3gaucherdisease
AT riesmarkus saccadicandneurologicaldeficitsintype3gaucherdisease
AT wiggsedythea saccadicandneurologicaldeficitsintype3gaucherdisease
AT bradyroscoeo saccadicandneurologicaldeficitsintype3gaucherdisease
AT schiffmannraphael saccadicandneurologicaldeficitsintype3gaucherdisease
AT fitzgibbonedmondj saccadicandneurologicaldeficitsintype3gaucherdisease